Entroflora Sachet Vanilla contains Saccharomyces boulardii 282.5 mg, a probiotic yeast widely used to support gastrointestinal health. This formulation is intended to restore and maintain the natural balance of intestinal flora, particularly during or following antibiotic therapy, acute diarrhea, or other conditions associated with dysbiosis. Saccharomyces boulardii is resistant to gastric acidity and bile salts, allowing it to reach the intestines viable and exert its beneficial effects. It acts by inhibiting the growth of pathogenic bacteria, modulating the immune response, and enhancing intestinal barrier function. Entroflora Sachet Vanilla is indicated for the prevention and treatment of antibiotic-associated diarrhea, traveler's diarrhea, and other forms of infectious diarrhea. The vanilla-flavored sachet facilitates ease of administration and improves patient compliance, especially in pediatric and adult populations. It is generally well tolerated with a low incidence of adverse effects. Use of Entroflora should be under medical supervision, particularly in immunocompromised patients or those with central venous catheters, due to rare reports of fungemia. The recommended dosage and duration of therapy depend on the clinical condition being treated. Entroflora Sachet Vanilla represents an effective adjunctive therapy for maintaining intestinal health and managing gastrointestinal disturbances.